Released Aug 13, 2019, after the close
10-Q filed Aug 13, 2019, 44 days after period end · 0001144204-19-039620
Q2 2019 · 10-Q
Revenue$0.00$0.00 — vs Q2 2018no prior Q1 2019 on file
Net Income-$1.78M-$1.78M N/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$2.13-$2.13 N/M vs Q2 2018N/M vs Q1 2019
Operating Income-$2,337,000N/M
Operating Cash Flowderived-$2,635,000N/M
Free Cash Flowderived-$2,636,000N/M
What the release said
The release
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$1.78M | -$1.85M | -$2.19M | -$2.97M |
| EPS Diluted | -$2.13 | -$0.16 | -$0.50 | -$1.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR